Is having a regular provider of diabetes care related to intensity of care and glycemic control?
- 1 October 1998
- journal article
- research article
- Vol. 47 (4) , 290-297
Abstract
BACKGROUND. We investigated whether having a regular health care provider for diabetes was related to the intensity of care, use of preventive services, or glycemic control in a well-defined population of adults with diabetes. METHODS. Adults with diabetes who were continuously enrolled in a health maintenance organization (HMO) for 1 year were identified by diagnostic and pharmacy databases (estimated sensitivity=0.91, positive predictive value = 0.94). In a stratified random sample, 1828 patients were sent a survey by mail that had a corrected response rate of 85.6%. Further data on utilization of services and glycosylated hemoglobin values were obtained from administrative databases and linked to survey responses. RESULTS. HMO members who reported having a regular health care provider (RP) for their diabetes (N = 1243) were comparable with those (N = 144) who denied having such a provider (NRP) in age, race, sex, comorbidity, and years of education, but had longer-duration diabetes (10.9 years vs 8.3 years; P = .002). After adjusting for age, sex, education level, duration of diabetes, and type of HMO clinic (owned vs contracted), RP subjects were more likely than NRPs (all P < .001) to follow a special diet for patients with diabetes (55% vs 33%), regularly monitor glucose levels at home (68% vs 47%), have greater frequency of glycosylated hemoglobin (Hb A(1c)) testing (65% vs 38%), have more foot examinations (42% vs 17%), have recommended cholesterol checks (77% vs 63%), and have had a recent preventive examination (86% vs 68%). Smaller differences favoring having a regular provider were noted for insulin use (48% vs 33%, odds ratio [OR] = 1.71, P = .013), for an influenza immunization within 1 year(65% vs 51%, P = .029), and for dilated retinal examinations (64% vs 51%, P < .027). No differences between groups were noted for dental checkups (69% vs 67%, P = .724) or likelihood of endocrinology referral (17% vs 10%, P = .104). Mean Hb A(1c) level was 8.2% (normal is <6.1%) in in the RP group and 8.6% in the NRP group (P = .182). Twelve percent of RPs and 24% of NRPs had an Hb A(1c) level of greater than 10% (chi(2) = 3.7, OR = 0.48, P = .05) after adjusting for age, sex, duration of diabetes, and education level. CONCLUSIONS. After adjustment for case mix, patients with diabetes who identified a regular primary health care provider for their diabetes were more likely to receive most recommended elements of diabetes care and to have better glycemic control than patients without such a provider. This effect was partially, but not completely, mediated by a higher number of clinic visits for those with a regular health care provider. Innovators seeking to improve diabetes care should be mindful of the relationship between having a regular primary health care provider and the quality of diabetes care.Keywords
This publication has 11 references indexed in Scilit:
- Continuous quality improvement can improve glycemic control for HMO patients with diabetesArchives of Family Medicine, 1996
- The Psychological Care of Patients with Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1996
- OUTCOMES OF PATIENTS WITH HYPERTENSION AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS TREATED BY DIFFERENT SYSTEMS AND SPECIALTIES - RESULTS FROM THE MEDICAL OUTCOMES STUDY1995
- Glycosylated Hemoglobin and the Risk of Microalbuminuria in Patients with Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- Hyperglycemie and Microvascular and Macrovascular Disease in DiabetesDiabetes Care, 1995
- United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three yearsBMJ, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- PREVALENCE OF DIABETES MELLITUS IN SOUTHERN WISCONSINAmerican Journal of Epidemiology, 1984
- A NEW HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURE TO QUANTITATE HEMOGLOBIN-A1C AND OTHER MINOR HEMOGLOBINS IN BLOOD OF NORMAL, DIABETIC, AND ALCOHOLIC INDIVIDUALS1983